LAB Similar Chart Price Prediction
The price of LAB is predicted to go up -29.85%, based on the high correlation periods with ASMB. The similarity of these two price pattern on the periods is 98.15%.
LAB
ASMB
Down: -29.85%Similarity: 98.15%
LAB Revenue Forecast
LAB EPS Forecast
LAB FAQs
What is LAB revenue forecast for next quarter？
What is LAB eps forecast for next quarter？
LAB Analyst's Forecast
Paul Knight
Keybanc
Buy → Hold
2025-02-27
Price Target
n/a
Downside
0%
KeyBanc analyst Paul Knight downgraded Standard BioTools to Sector Weight from Overweight without a price target. The company reported preannounced Q4 results with "disappointing" initial 2025 revenue guidance, the analyst tells investors in a research note. The firm says Standard Bio attributed its guidance to the proposed White House National Institutes of Health spending cut that may drive cautious spending for its academic customers. With a "tepid" spending environment and more meaningful commercial revenue from Illumina unlikely to occur until 2026, KeyBanc downgrades the shares.
Daniel Brennan
TD Cowen
Strong Buy
2024-10-31
Price Target
$2.75 → $2.5
Upside
+19.05%
